Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tom’s Of Maine Aims To Leverage Adult Sales Via Children’s Products

This article was originally published in The Tan Sheet

Executive Summary

Tom’s of Maine expands its children’s oral care portfolio with two toothpastes and a fluoride mouth rinse partly with hopes of bringing their parents into the fold as well, an associate brand manager says. The firm also is launching a natural toothbrush.

You may also be interested in...



In Brief: Lornamead Settles On Lice Claims; DASCA Introduced In House; FDA Warns Supplement Firms

Lornamead settles false claims allegations; DASCA bill introduced in House; FDA warns three firms about unapproved drug claims; Actavis expands manufacturing; Valeant defends reputation, Allergan bid; Tom’s Of Maine launches Toddler Training Toothpaste; and FDA to host Nutrition and Supplement Facts labels.

In Brief: Lornamead Settles On Lice Claims; DASCA Introduced In House; FDA Warns Supplement Firms

Lornamead settles false claims allegations; DASCA bill introduced in House; FDA warns three firms about unapproved drug claims; Actavis expands manufacturing; Valeant defends reputation, Allergan bid; Tom’s Of Maine launches Toddler Training Toothpaste; and FDA to host Nutrition and Supplement Facts labels.

Tom’s Of Maine Revamps Labeling, Adds Five Toothpaste Extensions

Two Tom's of Maine "homeopathic-style" toothpastes tailored toward alternative medicine adherents will be introduced in May

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel